SVB Leerink analyst Joseph Schwartz maintains Solid Biosciences (NASDAQ:SLDB) with a Market Perform and raises the price target from $1 to $6.
Here’s How Much You Would Have Made Owning Signature Bank Stock In The Last 15 Years
Signature Bank (NASDAQ:SBNY) has outperformed the market over the past 15 years by 9.78% on an annualized basis.